verapamil has been researched along with 5-[[(4-chlorophenyl)thio]methyl]-2-methyl-1H-pyrazol-3-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arvanites, AC; Benmohamed, R; Chen, T; Ferrante, RJ; Kirsch, DR; Morimoto, RI; Ralay Ranaivo, H; Silverman, RB; Watterson, DM | 1 |
1 other study(ies) available for verapamil and 5-[[(4-chlorophenyl)thio]methyl]-2-methyl-1H-pyrazol-3-one
Article | Year |
---|---|
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Enzyme Inhibitors; Humans; Magnetic Resonance Spectroscopy; Mice; Pyrazolones; Spectrometry, Mass, Electrospray Ionization; Superoxide Dismutase | 2011 |